Noninvasive Metabolic Profiling for Painless Diagnosis of Human Diseases and Disorders

References

• Gates SC , SweeleyCC. Quantitative metabolic profiling based on gas chromatography. Clin. Chem.24(10), 1663–1673 (1978).
   PubMed Web of Science ®Google Scholar
• Holmes E , WilsonID, NicholsonJK. Metabolic phenotyping in health and disease. Cell134(5), 714–717 (2008).
   PubMed Web of Science ®Google Scholar
• Kosmides AK , KamisogluK, CalvanoSE, CorbettSA, AndroulakisIP. Metabolomic fingerprinting: challenges and opportunities. Crit. Rev. Biomed. Eng.41(3), 205–221 (2013).
   PubMedGoogle Scholar
• Nicholson JK , LindonJC, HolmesE. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29(11), 1181–1189 (1999).
   PubMed Web of Science ®Google Scholar
• Harrigan GG , GoodacreR. Metabolic profiling: its role in biomarker discovery and gene function analysis. Kluwer Academic Publishers, Boston, MA, USA (2003).
   Google Scholar
• Fiehn O . Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genomics2(3), 155–168 (2001).
   PubMed Web of Science ®Google Scholar
• Morris M , WatkinsSM. Focused metabolomic profiling in the drug development process: advances from lipid profiling. Curr. Opin. Chem. Biol.9(4), 407–412 (2005).
   PubMed Web of Science ®Google Scholar
• Urpi-Sarda M , MonagasM, KhanNet al. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A1216(43), 7258–7267 (2009).
   PubMed Web of Science ®Google Scholar
• Dunn WB , BaileyNJ, JohnsonHE. Measuring the metabolome: current analytical technologies. Analyst130(5), 606–625 (2005).
   PubMed Web of Science ®Google Scholar
• Lindon JC , HolmesE, NicholsonJK. Metabonomics in pharmaceutical R&D. FEBS J.274(5), 1140–1151 (2007).
   PubMed Web of Science ®Google Scholar
• Goodacre R , BroadhurstD, SmildeAKet al. Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics3(3), 231–241 (2007).
   Web of Science ®Google Scholar
• Scalbert A , BrennanL, FiehnOet al. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics5(4), 435–458 (2009).
   PubMed Web of Science ®Google Scholar
• Monteiro MS , CarvalhoM, BastosML, Guedes De PinhoP. Metabolomics analysis for biomarker discovery: advances and challenges. Curr. Med. Chem.20(2), 257–271 (2013).
   PubMed Web of Science ®Google Scholar
• Emwas AH , LuchinatC, TuranoPet al. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics11(4), 872–894 (2015).
   PubMed Web of Science ®Google Scholar
• Emwas AH , RoyR, MckayRTet al. Recommendations and standardization of biomarker quantification using NMR-based metabolomics with particular focus on urinary analysis. J. Proteome Res. doi:10.1021/acs.jproteome.5b00885 (2016) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Klupczynska A , DerezinskiP, KokotZJ. Metabolomics in medical sciences – trends, challenges and perspectives. Acta Pol. Pharm.72(4), 629–641 (2015).
   PubMed Web of Science ®Google Scholar
• Brenner DE , RennertG. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?J. Natl Cancer Inst.97(15), 1107–1109 (2005).
   PubMedGoogle Scholar
• Medina S , Dominguez-PerlesR, GilJI, FerreresF, Gil-IzquierdoA. Metabolomics and the diagnosis of human diseases – a guide to the markers and pathophysiological pathways affected. Curr. Med. Chem.21(7), 823–848 (2014).
   PubMed Web of Science ®Google Scholar
• Chan EC , MalM, PasikantiKK. Metabonomics. In: Handbook of Separation Science: Gas Chromatography. PooleCF ( Ed.). Elsevier, PA, USA, 545–562 (2012).
   Google Scholar
• Cao DL , YeDW, ZhangHL, ZhuY, WangYX, YaoXD. A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. Prostate71(7), 700–710 (2011).
   PubMed Web of Science ®Google Scholar
• Yang J , XuG, ZhengYet al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci.813(1–2), 59–65 (2004).
   PubMed Web of Science ®Google Scholar
• Frickenschmidt A , FrohlichH, BullingerDet al. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Biomarkers13(4), 435–449 (2008).
   PubMed Web of Science ®Google Scholar
• Fan X , BaiJ, ShenP. Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods. Conf. Proc. IEEE Eng. Med. Biol. Soc.6, 6081–6084 (2005).
   Google Scholar
• Wang WZ , ZhaoXJ, LiX, ChenJ, LiFL, XuGW. [Lung cancer diagnosis based on urinary modified nucleoside metabolic profiling]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao.29(6), 738–741 (2007).
   PubMedGoogle Scholar
• Duarte IF , RochaCM, GilAM. Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis. Expert Rev. Mol. Diag.13(7), 737–748 (2013).
   PubMed Web of Science ®Google Scholar
• Silva CL , PassosM, CamaraJS. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers – a powerful strategy for breast cancer diagnosis. Talanta89, 360–368 (2012).
   PubMed Web of Science ®Google Scholar
• Pasikanti KK , EsuvaranathanK, HoPCet al. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J. Proteome Res.9(6), 2988–2995 (2010).
   PubMed Web of Science ®Google Scholar
• Jin X , YunSJ, JeongP, KimIY, KimWJ, ParkS. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Oncotarget5(6), 1635–1645 (2014).
   PubMedGoogle Scholar
• Hong Y , EsuvaranathanK, PasikantiKK, Yong ChanEC. Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?Bioanalysis7(21), 2727–2729 (2015).
   PubMed Web of Science ®Google Scholar
• Shen C , SunZ, ChenDet al. Developing urinary metabolomic signatures as early bladder cancer diagnostic markers. Omics19(1), 1–11 (2015).
   PubMed Web of Science ®Google Scholar
• Jung J , JungY, BangEJet al. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling. Annals Surg. Oncol.21(Suppl. 4), S736–S742 (2014).
   PubMedGoogle Scholar
• Furina RR , RyzhkovVL, MitrakovaNNet al. [The method for early diagnosis of the gastric cancer based metabolomics research]. Eksp. Klin. Gastroenterol.10, 14–17 (2014).
   Google Scholar
• Vaidyanathan K . Urinary proteomics and metabolomics in the diagnosis of pediatric disorders. Proteomics Clin. Appl.9(5–6), 482–489 (2015).
   PubMed Web of Science ®Google Scholar
• Kouremenos KA , PittJ, MarriottPJ. Metabolic profiling of infant urine using comprehensive two-dimensional gas chromatography: Application to the diagnosis of organic acidurias and biomarker discovery. J. Chromatogr. A1217(1), 104–111 (2010).
   PubMed Web of Science ®Google Scholar
• Shinka T , InoueY, PengH, Zhen-WeiX, OseM, KuharaT. Urine screening of five-day-old newborns: metabolic profiling of neonatal galactosuria. J. Chromatogr. B Biomed. Sci. Appl.732(2), 469–477 (1999).
   PubMedGoogle Scholar
• Janeckova H , KalivodovaA, NajdekrLet al. Untargeted metabolomic analysis of urine samples in the diagnosis of some inherited metabolic disorders. Biomedical Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub.159(4), 582–585 (2014).
   PubMed Web of Science ®Google Scholar
• Wang M , YangX, RenLet al. Biomarkers identified by urinary metabonomics for noninvasive diagnosis of nutritional rickets. J. Proteome Res.13(9), 4131–4142 (2014).
   PubMed Web of Science ®Google Scholar
• Wei H , PasmanW, RubinghCet al. Urine metabolomics combined with the personalized diagnosis guided by Chinese medicine reveals subtypes of pre-diabetes. Mol. Biosyst.8(5), 1482–1491 (2012).
   PubMedGoogle Scholar
• Xiong X , ShengX, LiuD, ZengT, PengY, WangY. A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria. Anal. Bioanal. Chem.407(29), 8825–8833 (2015).
   PubMed Web of Science ®Google Scholar
• Kenny LC , BroadhurstDI, DunnWet al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension56(4), 741–749 (2010).
   PubMed Web of Science ®Google Scholar
• Austdal M , TangerasLH, SkrastadRBet al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int. J. Mol. Sci.16(9), 21520–21538 (2015).
   PubMed Web of Science ®Google Scholar
• Blydt-Hansen TD , SharmaA, GibsonIW, MandalR, WishartDS. Urinary metabolomics for noninvasive detection of borderline and acute T cell-mediated rejection in children after kidney transplantation. Am. J. Transplant.14(10), 2339–2349 (2014).
   PubMed Web of Science ®Google Scholar
• De Preter V . Metabolomics in the clinical diagnosis of inflammatory bowel disease. Digest. Dis.33(Suppl. 1), 2–10 (2015).
   PubMedGoogle Scholar
• Godoy MM , LopesEP, SilvaROet al. Hepatitis C virus infection diagnosis using metabonomics. J. Viral Hepatitis17(12), 854–858 (2010).
   PubMed Web of Science ®Google Scholar
• Hou LJ , WangHW, WeiXXet al. Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients. Iran. Red Crescent Med. J.17(4), e27359 (2015).
   PubMed Web of Science ®Google Scholar
• Lam CW , LawCY, ToKKet al. NMR-based metabolomic urinalysis: a rapid screening test for urinary tract infection. Clin. Chim. Acta436, 217–223 (2014).
   PubMed Web of Science ®Google Scholar
• Lam CW , LawCY, SzeKH, ToKK. Quantitative metabolomics of urine for rapid etiological diagnosis of urinary tract infection: evaluation of a microbial-mammalian co-metabolite as a diagnostic biomarker. Clin. Chim. Acta438, 24–28 (2015).
   PubMed Web of Science ®Google Scholar
• Pike AW , KleinJL, GotlinRW, FennesseyPV. The role of steroid metabolic profiling as an aid in the diagnosis of familial precocious puberty, a subgroup of true precocious puberty. J. Inherit. Metabol. Dis.9(2), 147–155 (1986).
   PubMed Web of Science ®Google Scholar
• Priori R , ScrivoR, BrandtJet al. Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. Autoimmun. Rev.12(10), 1022–1030 (2013).
   PubMed Web of Science ®Google Scholar
• Van QN , KloseJR, LucasDAet al. The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis. Dis. Markers19(4–5), 169–183 (2003).
   PubMed Web of Science ®Google Scholar
• Alvarez-Sanchez B , Priego-CapoteF, Luque De CastroMD. Study of sample preparation for metabolomic profiling of human saliva by liquid chromatography-time of flight/mass spectrometry. J. Chromatogr. A1248, 178–181 (2012).
   PubMed Web of Science ®Google Scholar
• Mueller DC , PillerM, NiessnerR, SchererM, SchererG. Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS method. J. Proteome Res.13(3), 1602–1613 (2014).
   PubMed Web of Science ®Google Scholar
• Bertram HC , EggersN, EllerN. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Anal. Chem.81(21), 9188–9193 (2009).
   PubMed Web of Science ®Google Scholar
• Ai JY , SmithB, WongDT. Bioinformatics advances in saliva diagnostics. Int. J. Oral Sci.4(2), 85–87 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang A , SunH, WangX. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl. Biochem. Biotechnol.168(6), 1718–1727 (2012).
   PubMed Web of Science ®Google Scholar
• Cuevas-Cordoba B , Santiago-GarciaJ. Saliva: a fluid of study for OMICS. Omics18(2), 87–97 (2014).
   PubMed Web of Science ®Google Scholar
• Mikkonen JJ , SinghSP, HerralaM, LappalainenR, MyllymaaS, KullaaAM. Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases. J. Periodontal Res. doi:10.1111/jre.12327 (2015) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Schafer CA , SchaferJJ, YakobM, LimaP, CamargoP, WongDT. Saliva diagnostics: utilizing oral fluids to determine health status. Monogr. Oral Sci.24, 88–98 (2014).
   PubMedGoogle Scholar
• Shankar AA , AlexS, RoutrayS. Incorporation of salivary metabolomics in oral cancer diagnostics. Oral Oncol.50(10), e53–e54 (2014).
   PubMed Web of Science ®Google Scholar
• Sugimoto M , WongDT, HirayamaA, SogaT, TomitaM. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics6(1), 78–95 (2010).
   PubMed Web of Science ®Google Scholar
• Barnes VM , KennedyAD, PanagakosFet al. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease. PLoS ONE9(8), e105181 (2014).
   PubMed Web of Science ®Google Scholar
• de Laurentiis G , ParisD, MelckDet al. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J. Proteome Res.12(3), 1502–1511 (2013).
   PubMed Web of Science ®Google Scholar
• Mook-Kanamori DO , SelimMM, TakiddinAHet al. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. J. Clin. Endocrinol. Metabol.99(3), E479–E483 (2014).
   PubMed Web of Science ®Google Scholar
• Takayama T , KuwabaraT, MaedaTet al. Profiling of chiral and achiral carboxylic acid metabolomics: synthesis and evaluation of triazine-type chiral derivatization reagents for carboxylic acids by LC-ESI-MS/MS and the application to saliva of healthy volunteers and diabetic patients. Anal. Bioanal. Chem.407(3), 1003–1014 (2015).
   PubMed Web of Science ®Google Scholar
• Kageyama G , SaegusaJ, IrinoYet al. Metabolomics analysis of saliva from patients with primary Sjogren’s syndrome. Clin. Exp. Immunol.182(2), 149–153 (2015).
   PubMed Web of Science ®Google Scholar
• Tsuruoka M , HaraJ, HirayamaAet al. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis34(19), 2865–2872 (2013).
   PubMed Web of Science ®Google Scholar
• Yan SK , WeiBJ, LinZY, YangY, ZhouZT, ZhangWD. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol.44(5), 477–483 (2008).
   PubMed Web of Science ®Google Scholar
• Wei J , XieG, ZhouZet al. Salivary metabolite signatures of oral cancer and leukoplakia. Int. J. Cancer129(9), 2207–2217 (2011).
   PubMed Web of Science ®Google Scholar
• Wang Q , GaoP, WangX, DuanY. The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci. Rep.4, 6802 (2014).
   PubMed Web of Science ®Google Scholar
• Bos LD , Van WalreeIC, KolkAH, JanssenHG, SterkPJ, SchultzMJ. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. J. Appl. Physiol.115(10), 1487–1495 (2013).
   PubMed Web of Science ®Google Scholar
• de Laurentiis G , ParisD, MelckDet al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J.32(5), 1175–1183 (2008).
   PubMed Web of Science ®Google Scholar
• Basanta M , JarvisRM, XuYet al. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst135(2), 315–320 (2010).
   PubMed Web of Science ®Google Scholar
• Fens N , DoumaRA, SterkPJ, KamphuisenPW. Breathomics as a diagnostic tool for pulmonary embolism. J. Thromb. Haemost.8(12), 2831–2833 (2010).
   PubMed Web of Science ®Google Scholar
• Sofia M , ManiscalcoM, De LaurentiisG, ParisD, MelckD, MottaA. Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate. J. Biomed. Biotechnol.2011, 403260 (2011).
   PubMedGoogle Scholar
• Guallar-Hoyas C , TurnerMA, BlackburnGJ, WilsonID, ThomasCL. A workflow for the metabolomic/metabonomic investigation of exhaled breath using thermal desorption GC-MS. Bioanalysis4(18), 2227–2237 (2012).
   PubMed Web of Science ®Google Scholar
• Bos LD , WedaH, WangYet al. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur. Respir. J.44(1), 188–197 (2014).
   PubMed Web of Science ®Google Scholar
• Van Der Schee MP , PaffT, BrinkmanP, Van AalderenWM, HaarmanEG, SterkPJ. Breathomics in lung disease. Chest147(1), 224–231 (2015).
   PubMed Web of Science ®Google Scholar
• Motta A , ParisD, MelckDet al. Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur. Respir. J.39(2), 498–500 (2012).
   PubMed Web of Science ®Google Scholar
• Krilaviciute A , HeissJA, LejaM, KupcinskasJ, HaickH, BrennerH. Detection of cancer through exhaled breath: a systematic review. Oncotarget6(36), 38643–38657 (2015).
   PubMedGoogle Scholar
• Carraro S , GiordanoG, RenieroFet al. Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy68(1), 110–117 (2013).
   PubMed Web of Science ®Google Scholar
• Gahleitner F , Guallar-HoyasC, BeardsmoreCS, PandyaHC, ThomasCP. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath. Bioanalysis5(18), 2239–2247 (2013).
   PubMed Web of Science ®Google Scholar
• Ibrahim B , MarsdenP, SmithJA, CustovicA, NilssonM, FowlerSJ. Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma. Allergy68(8), 1050–1056 (2013).
   PubMed Web of Science ®Google Scholar
• Motta A , ParisD, D’AmatoMet al. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J. Proteome Res.13(12), 6107–6120 (2014).
   PubMed Web of Science ®Google Scholar
• Carraro S , RezziS, RenieroFet al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am. J. Respir. Crit. Care Med.175(10), 986–990 (2007).
   PubMed Web of Science ®Google Scholar
• Mangler M , FreitagC, LanowskaM, StaeckO, SchneiderA, SpeiserD. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Ginekol. Pol.83(10), 730–736 (2012).
   PubMed Web of Science ®Google Scholar
• Li J , PengY, LiuYet al. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry. Clin. Chim. Acta436, 59–67 (2014).
   PubMed Web of Science ®Google Scholar
• Montuschi P , ParisD, MelckDet al. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax67(3), 222–228 (2012).
   PubMed Web of Science ®Google Scholar
• Monge ME , PerezJJ, DwivediPet al. Ion mobility and liquid chromatography/mass spectrometry strategies for exhaled breath condensate glucose quantitation in cystic fibrosis studies. Rapid Comm. Mass Spec.27(20), 2263–2271 (2013).
   PubMed Web of Science ®Google Scholar
• Qin T , LiuH, SongQet al. The screening of volatile markers for hepatocellular carcinoma. Cancer Epidemiol. Biomark. Prev.19(9), 2247–2253 (2010).
   PubMed Web of Science ®Google Scholar
• Kalluri U , NaikerM, MyersMA. Cell culture metabolomics in the diagnosis of lung cancer-the influence of cell culture conditions. J. Breath Res.8(2), 027109 (2014).
   PubMed Web of Science ®Google Scholar
• Handa H , UsubaA, MaddulaS, BaumbachJI, MineshitaM, MiyazawaT. Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PLoS ONE9(12), e114555 (2014).
   PubMed Web of Science ®Google Scholar
• Song G , QinT, LiuHet al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer67(2), 227–231 (2010).
   PubMed Web of Science ®Google Scholar
• Wang Y , HuY, WangDet al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Cancer Biomark.11(4), 129–137 (2012).
   PubMed Web of Science ®Google Scholar
• Zou Y , ZhangX, ChenX, HuY, YingK, WangP. Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease. Cancer Biomark.14(5), 371–379 (2014).
   PubMed Web of Science ®Google Scholar
• Lamote K , NackaertsK, Van MeerbeeckJP. Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis. Cancer Epidemiol. Biomark. Prev.23(6), 898–908 (2014).
   PubMed Web of Science ®Google Scholar
• Montuschi P , ParisD, MontellaSet al. Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis. Am. J. Respir. Crit. Care Med.190(2), 229–233 (2014).
   PubMed Web of Science ®Google Scholar
• Fowler SJ , Basanta-SanchezM, XuY, GoodacreR, DarkPM. Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study. Thorax70(4), 320–325 (2015).
   PubMed Web of Science ®Google Scholar
• Bezabeh T , SomorjaiRL, SmithIC. MR metabolomics of fecal extracts: applications in the study of bowel diseases. Magn. Res. Chem.47(Suppl. 1), S54–S61 (2009).
   PubMedGoogle Scholar
• Gao X , Pujos-GuillotE, MartinJFet al. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal. Biochem.393(2), 163–175 (2009).
   PubMed Web of Science ®Google Scholar
• Xu W , ChenD, WangNet al. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal. Chem.87(2), 829–836 (2015).
   PubMed Web of Science ®Google Scholar
• Ahmed I , GreenwoodR, Costello BdeL, RatcliffeNM, ProbertCS. An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS ONE8(3), e58204 (2013).
   PubMed Web of Science ®Google Scholar
• Le Gall G , NoorSO, RidgwayKet al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J. Proteome Res.10(9), 4208–4218 (2011).
   PubMed Web of Science ®Google Scholar
• Monleon D , MoralesJM, BarrasaA, LopezJA, VazquezC, CeldaB. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed.22(3), 342–348 (2009).
   PubMed Web of Science ®Google Scholar
• Goedert JJ , SampsonJN, MooreSCet al. Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis35(9), 2089–2096 (2014).
   PubMed Web of Science ®Google Scholar
• Phua LC , ChueXP, KohPK, CheahPY, HoHK, ChanEC. Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol. Ther.15(4), 389–397 (2014).
   PubMed Web of Science ®Google Scholar
• Walker A , LucioM, PfitznerBet al. Importance of sulfur-containing metabolites in discriminating fecal extracts between normal and Type-2 diabetic mice. J. Proteome Res.13(10), 4220–4231 (2014).
   PubMed Web of Science ®Google Scholar
• Inagaki S , NodaT, MinJZ, Toyo’okaT. Metabolic profiling of rat hair and screening biomarkers using ultra performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry. J. Chromatogr. A1176(1–2), 94–99 (2007).
   PubMed Web of Science ®Google Scholar
• Gonska T , IpW, TurnerDet al. Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Thorax64(11), 932–938 (2009).
   PubMed Web of Science ®Google Scholar
• Calderon-Santiago M , Priego-CapoteF, TurckNet al. Human sweat metabolomics for lung cancer screening. Anal. Bioanal. Chem.407(18), 5381–5392 (2015).
   PubMed Web of Science ®Google Scholar
• Chalasani N , YounossiZ, LavineJEet al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology55(6), 2005–2023 (2012).
   PubMed Web of Science ®Google Scholar
• Wruck W , KashoferK, RehmanSet al. Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes. Sci. Data2, 150068 (2015).
   PubMed Web of Science ®Google Scholar
• Chen L , ZhouL, ChanEC, NeoJ, BeuermanRW. Characterization of the human tear metabolome by LC-MS/MS. J. Proteome Res.10(10), 4876–4882 (2011).
   PubMed Web of Science ®Google Scholar
• Pieragostino D , D’AlessandroM, Di IoiaM, Di IlioC, SacchettaP, Del BoccioP. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases. Proteomics Clin. Appl.9(1–2), 169–186 (2015).
   PubMed Web of Science ®Google Scholar